NCT00648557View on ClinicalTrials.gov

Fasting Study of Levothyroxine Sodium Tablets 200 mg to Synthroid Tablets 200 mg

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

March 31, 2003

Study Completion Date

March 31, 2003

Conditions
Healthy
Interventions
DRUG

Levothyroxine Sodium Tablets 200 mg

3x200mcg, single dose fasting

DRUG

Synthroid Tablets 200 mg

3x200mcg, single dose fasting

Trial Locations (1)

58104

PRACS Institute, Ltd., Fargo

Sponsors
All Listed Sponsors
lead

Mylan Pharmaceuticals Inc

INDUSTRY

NCT00648557 - Fasting Study of Levothyroxine Sodium Tablets 200 mg to Synthroid Tablets 200 mg | Biotech Hunter | Biotech Hunter